DekaBank Deutsche Girozentrale’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$757K Hold
75,000
﹤0.01% 914
2025
Q1
$569K Hold
75,000
﹤0.01% 952
2024
Q4
$861K Hold
75,000
﹤0.01% 898
2024
Q3
$1.54M Hold
75,000
﹤0.01% 809
2024
Q2
$1.76M Hold
75,000
﹤0.01% 783
2024
Q1
$1.99M Sell
75,000
-3,129
-4% -$83K ﹤0.01% 759
2023
Q4
$2.5M Buy
78,129
+25,000
+47% +$799K 0.01% 733
2023
Q3
$1.68M Buy
53,129
+3,129
+6% +$99.2K ﹤0.01% 781
2023
Q2
$2.1M Hold
50,000
﹤0.01% 739
2023
Q1
$1.77M Buy
50,000
+10,000
+25% +$354K ﹤0.01% 743
2022
Q4
$1.39M Hold
40,000
﹤0.01% 804
2022
Q3
$2.18M Buy
40,000
+7,000
+21% +$381K 0.01% 691
2022
Q2
$1.7M Buy
33,000
+1,300
+4% +$67K ﹤0.01% 757
2022
Q1
$2.29M Buy
31,700
+6,600
+26% +$476K 0.01% 724
2021
Q4
$2.94M Buy
25,100
+600
+2% +$70.4K 0.01% 688
2021
Q3
$3.35M Hold
24,500
0.01% 623
2021
Q2
$3.91M Sell
24,500
-2,000
-8% -$319K 0.01% 584
2021
Q1
$1.95M Buy
26,500
+7,700
+41% +$568K 0.01% 704
2020
Q4
$1.02M Buy
18,800
+3,100
+20% +$169K ﹤0.01% 865
2020
Q3
$335K Buy
+15,700
New +$335K ﹤0.01% 986
2019
Q3
Sell
-32,600
Closed -$496K 1083
2019
Q2
$496K Buy
32,600
+12,600
+63% +$192K ﹤0.01% 920
2019
Q1
$624K Buy
20,000
+3,700
+23% +$115K ﹤0.01% 862
2018
Q4
$200K Sell
16,300
-3,700
-19% -$45.4K ﹤0.01% 967
2018
Q3
$624K Sell
20,000
-13,500
-40% -$421K ﹤0.01% 883
2018
Q2
$905K Buy
33,500
+3,000
+10% +$81K 0.01% 771
2018
Q1
$645K Buy
30,500
+25,900
+563% +$548K ﹤0.01% 820
2017
Q4
$76K Hold
4,600
﹤0.01% 1002
2017
Q3
$76K Hold
4,600
﹤0.01% 1010
2017
Q2
$75K Buy
+4,600
New +$75K ﹤0.01% 986